Pediatric Emergencies — Part 5: Common Surgical Emergencies, Trauma & Neonatal Emergencies
Intussusception, pyloric stenosis, testicular torsion, PECARN head CT and abdominal trauma decision rules, solid organ injury non-operative management, non-accidental trauma screening, neonatal emergencies including hypoglycemia, congenital heart disease with PGE1, hyperbilirubinemia, and a comprehensive pediatric medication dosing reference table.
1. Intussusception
Intussusception is the most common cause of intestinal obstruction in children aged 3 months to 6 years, with a peak incidence at 5-10 months. It occurs when a proximal segment of bowel (intussusceptum) telescopes into an adjacent distal segment (intussuscipiens), most commonly at the ileocolic junction. The majority of cases in children are idiopathic, thought to be triggered by hypertrophied Peyer patches following viral illness. A pathologic lead point (Meckel diverticulum, polyp, lymphoma, duplication cyst) is more likely in children <3 months or >5 years.1
1.1 Clinical Presentation
Classic triad (present in <50% of cases):
| Feature | Description |
|---|---|
| Intermittent colicky abdominal pain | Episodes of severe, crampy pain occurring every 15-20 minutes; child draws up legs, becomes pale, and screams; may appear well between episodes |
| Vomiting | Initially non-bilious; may become bilious as obstruction progresses |
| Currant jelly stool | Blood and mucus mixed stool; a late finding indicating mucosal ischemia; present in only 20-40% at presentation |
Additional findings:
- Palpable sausage-shaped mass in right upper quadrant or epigastrium (present in 60% when carefully examined)
- Empty right lower quadrant (Dance sign)
- Lethargy (may be the sole presenting complaint in 10% — can mimic sepsis or meningitis)
- Altered mental status without other obvious cause in an infant should raise suspicion for intussusception
1.2 Diagnostic Imaging
| Modality | Findings | Sensitivity / Specificity |
|---|---|---|
| Ultrasound (first-line) | Target sign (donut sign) on transverse view — concentric rings of bowel wall and mesentery; pseudo-kidney sign on longitudinal view; may identify lead point; assess for free fluid | Sensitivity 97-100%; Specificity 88-100% |
| Plain abdominal radiograph | May show: soft tissue mass, paucity of gas in RLQ, small bowel obstruction pattern; normal film does NOT exclude intussusception | Sensitivity 45-75%; not adequate to exclude diagnosis |
| Contrast enema (diagnostic and therapeutic) | Meniscus sign on barium enema; coiled-spring appearance | 95-100% sensitivity; largely replaced by ultrasound for diagnosis |
1.3 Management
| Scenario | Treatment | Details |
|---|---|---|
| Uncomplicated intussusception | Air enema reduction (preferred) or hydrostatic reduction (ultrasound-guided saline/water-soluble contrast) | Success rate 80-95% for air enema; performed by pediatric radiologist; surgical consultation should be obtained prior to reduction attempt |
| Reduction protocol | Air enema: insufflation pressures typically 80-120 mmHg (max 120 mmHg); three attempts of 3 minutes each with rest periods between | Successful reduction confirmed by free flow of air or contrast into terminal ileum with resolution of mass on ultrasound |
| Post-reduction observation | Admit for observation × 12-24 hours | Recurrence rate 5-10% (most within 72 hours); higher recurrence with longer duration of symptoms or multiple episodes |
| Contraindications to enema reduction | Peritonitis, perforation, hemodynamic instability, prolonged symptoms (>48 hours is relative contraindication) | Proceed to surgical exploration |
| Failed reduction (after 3 attempts) | Surgical reduction (manual reduction at laparotomy or laparoscopy) ± bowel resection if necrotic bowel found | |
| Recurrent intussusception (≥3 episodes) | Surgical exploration to evaluate for pathologic lead point |
2. Pyloric Stenosis
Hypertrophic pyloric stenosis (HPS) is the most common surgical cause of vomiting in infants, typically presenting between 2-8 weeks of age (peak 3-5 weeks). It results from hypertrophy and hyperplasia of the pyloric muscle, causing progressive gastric outlet obstruction. Male infants are affected 4-5 times more frequently than females, with firstborn males at highest risk.2
2.1 Clinical Presentation
| Feature | Description |
|---|---|
| Projectile, non-bilious vomiting | Occurs immediately after feeding; forceful — may travel several feet; infant is hungry and eager to re-feed immediately after vomiting (“hungry vomiter”) |
| Progressive | Worsens over days to weeks; initially intermittent, becomes consistent |
| Dehydration | Depending on duration; sunken fontanelle, decreased urine output, poor skin turgor |
| Weight loss or failure to gain | Caloric deprivation from vomiting |
| Olive-shaped mass | Palpable in right upper quadrant/epigastrium in 60-80% of cases when examined carefully (best palpated with infant relaxed, stomach empty — may need NG decompression first) |
| Visible gastric peristalsis | Peristaltic waves moving left to right across upper abdomen |
2.2 Metabolic Derangement
The hallmark metabolic abnormality is hypochloremic, hypokalemic metabolic alkalosis caused by loss of gastric HCl:
| Abnormality | Mechanism |
|---|---|
| Metabolic alkalosis (elevated HCO3) | Loss of H⁺ ions in vomited gastric acid |
| Hypochloremia (low Cl⁻) | Loss of Cl⁻ in vomited gastric acid |
| Hypokalemia (low K⁺) | Renal K⁺ wasting (kidney excretes K⁺ to retain H⁺ as it attempts to correct alkalosis); also direct loss in vomitus |
| Paradoxical aciduria | Kidney prioritizes Na⁺ reabsorption over acid-base correction when volume depleted; excretes H⁺ instead of retaining it |
| Hyponatremia (variable) | Volume depletion stimulates ADH; additionally, sodium conservation may be impaired |
2.3 Diagnostic Criteria (Ultrasound)
Ultrasound is the imaging modality of choice (sensitivity >95%, specificity ~100%):
| Parameter | Diagnostic Threshold | Notes |
|---|---|---|
| Pyloric muscle thickness | ≥3 mm (single wall) | Measured as the hypoechoic ring surrounding the echogenic mucosa |
| Pyloric channel length | ≥16 mm (some sources use ≥15 mm) | Measured on longitudinal view |
| Pyloric diameter | ≥14 mm | Overall cross-sectional diameter |
| Failure of pyloric opening | No passage of gastric contents through pylorus during real-time observation | Functional assessment |
2.4 Management
| Step | Intervention | Details |
|---|---|---|
| 1 | NPO and NG tube | Decompress stomach; prevent aspiration |
| 2 | IV fluid resuscitation | NS or LR bolus 20 mL/kg if dehydrated; then D5NS (or D5 0.45% NS) + 20-40 mEq/L KCl for maintenance; goal: correct alkalosis, replete chloride and potassium BEFORE surgery |
| 3 | Pre-operative targets | Serum Cl >100 mEq/L; serum K >3.5 mEq/L; serum HCO3 <30 mEq/L; adequate urine output; may take 12-48 hours of IV fluids |
| 4 | Pyloromyotomy | Ramstedt pyloromyotomy (open or laparoscopic); incision through hypertrophied pyloric muscle down to but not through the mucosa; cure rate ~100% |
| 5 | Post-operative feeding | Advance feeds within 4-6 hours post-operatively; small, frequent feeds; emesis is common in the first 24-48 hours and does not indicate surgical failure |
Key point: pyloric stenosis is a medical emergency (dehydration, electrolyte imbalance) but a surgical semi-urgency — the metabolic derangement must be corrected before anesthesia (alkalosis causes respiratory depression, hypokalemia causes arrhythmias)2
3. Testicular Torsion
Testicular torsion is a urologic emergency caused by twisting of the spermatic cord, leading to ischemia and potential infarction of the testicle. It has a bimodal age distribution: neonatal period and pubertal age (12-18 years). Timely diagnosis and surgical intervention are critical — testicular salvage rates decline sharply with increasing time from symptom onset.3
3.1 Clinical Features
| Feature | Testicular Torsion | Torsion of Appendage Testis | Epididymitis |
|---|---|---|---|
| Age | Neonatal; 12-18 years | 7-14 years (pre-pubertal) | Post-pubertal (>14 years) |
| Onset | Sudden, severe | Gradual (hours to days) | Gradual (days) |
| Pain | Severe; may radiate to lower abdomen/inguinal region | Mild to moderate; localized to upper pole | Progressive; may be mild initially |
| Nausea/vomiting | Common (50%) | Uncommon | Uncommon |
| Cremasteric reflex | Absent (highly specific) | Present | Present |
| Testicular lie | High-riding; transverse | Normal | Normal |
| Prehn sign | Negative (elevation does not relieve pain) | Variable | Positive (elevation may relieve pain) |
| Blue dot sign | Absent | Present (tender blue nodule at upper pole — visible through thin scrotal skin) | Absent |
| Swelling | Diffuse testicular; may be hard | Localized to appendage | Epididymal tenderness; may progress to orchitis |
| Urinalysis | Normal | Normal | May show pyuria |
3.2 Time to Intervention and Salvage Rates
| Time from Symptom Onset | Testicular Salvage Rate |
|---|---|
| <6 hours | 90-100% |
| 6-12 hours | 50-70% |
| 12-24 hours | 20-40% |
| >24 hours | <10% |
3.3 Management
| Decision Point | Action |
|---|---|
| High clinical suspicion (acute onset, absent cremasteric reflex, high-riding testis) | Immediate surgical exploration — do NOT delay for imaging |
| Moderate suspicion | Urgent Doppler ultrasound — absent or decreased intratesticular blood flow supports diagnosis; sensitivity 86-100%, specificity 95-100%; a normal ultrasound does NOT fully exclude early or intermittent torsion |
| Manual detorsion (temporizing) | Open the book (outward rotation — lateral to medial): rotate affected testis toward the thigh (as if opening a book); attempt 1-3 full turns (360-1080 degrees); relief of pain suggests successful detorsion; still requires urgent surgical exploration and orchiopexy |
| Surgical exploration | Detorsion of the affected testis + bilateral orchiopexy (fixation of both testes to prevent recurrence on either side); orchiectomy if testis is non-viable |
Key point: testicular torsion is a clinical diagnosis — no imaging study should delay surgical exploration when clinical suspicion is high. The goal is time from symptom onset to detorsion <6 hours.3
4. Pediatric Trauma
Trauma is the leading cause of death in children over 1 year of age. Pediatric trauma evaluation follows the same ABCDE primary survey framework as adults, with critical pediatric-specific modifications. Key differences include proportionally larger head size, more compliant (elastic) skeleton with increased risk of internal injury without fractures, and greater body surface area-to-mass ratio increasing hypothermia risk.4 5
4.1 PECARN Head CT Decision Rule
The Pediatric Emergency Care Applied Research Network (PECARN) head injury prediction rule is the largest and most well-validated clinical decision rule for identifying children at very low risk for clinically-important traumatic brain injury (ciTBI), defined as TBI causing death, neurosurgery, intubation >24 hours, or hospital admission ≥2 nights. It was derived and validated in a cohort of over 42,000 children. Application of this rule can safely reduce unnecessary CT scans by 25-30% and their associated radiation exposure.4
Children <2 Years of Age
GCS ≤14, or palpable skull fracture,
or altered mental status?
/ \
YES NO
| |
→ CT recommended Are ANY of the following present?
(ciTBI risk • Occipital, parietal, or temporal
4.4%) scalp hematoma
• Loss of consciousness ≥5 seconds
• Severe mechanism of injury*
• Not acting normally per parent
/ \
YES NO
| |
→ CT vs observation → CT NOT
(ciTBI risk 0.9%) recommended
Observation (ciTBI risk
preferred if: <0.02%)
• Age ≥3 months
• Isolated finding
• Mild symptoms
• Improving
• Reliable follow-up
Children ≥2 Years of Age
GCS ≤14, or signs of basilar skull fracture,
or altered mental status?
/ \
YES NO
| |
→ CT recommended Are ANY of the following present?
(ciTBI risk • Loss of consciousness
4.3%) • Vomiting
• Severe mechanism of injury*
• Severe headache
/ \
YES NO
| |
→ CT vs observation → CT NOT
(ciTBI risk 0.8%) recommended
Observation (ciTBI risk
preferred if: <0.05%)
• Isolated finding
• Mild symptoms
• Improving
• Reliable follow-up
*Severe mechanism of injury:
- Motor vehicle crash with patient ejection, rollover, or death of another passenger
- Pedestrian or bicycle rider struck by motor vehicle without helmet
- Fall >3 feet (children <2 years) or >5 feet (children ≥2 years)
- Head struck by a high-impact object
4.2 PECARN Abdominal Trauma Rule
The PECARN abdominal trauma prediction rule identifies children at very low risk for intra-abdominal injury requiring acute intervention (IAI-I), reducing unnecessary CT scans in pediatric blunt abdominal trauma.5
Very low risk (CT not recommended) if ALL of the following are absent:
| Risk Factor | Definition |
|---|---|
| Evidence of abdominal wall trauma or seat belt sign | Abrasion, contusion, or seat belt mark across the abdomen |
| GCS <14 | Altered mental status |
| Abdominal tenderness | Tenderness on examination |
| Thoracic wall trauma | Signs of chest wall injury (suggests high-energy mechanism) |
| Complaint of abdominal pain | Subjective pain report |
| Decreased breath sounds | May indicate hemothorax or diaphragm injury |
| Vomiting | Any vomiting after the traumatic event |
If ALL seven factors are absent: risk of IAI-I is <0.1% — CT can be safely deferred.
If ANY factor is present: clinical judgment regarding CT; further risk stratification based on number and severity of findings.
4.3 Solid Organ Injury: Non-Operative Management
Non-operative management (NOM) is the standard of care for hemodynamically stable children with blunt splenic and hepatic injuries, with success rates exceeding 90-95% for all grades of injury. This represents a major paradigm shift from historical practice and is more aggressively applied in children than adults.6
Spleen Injury Grading and Management
| AAST Grade | Description | NOM Protocol |
|---|---|---|
| I | Subcapsular hematoma <10% surface area; laceration <1 cm depth | ICU: 0 days; Bed rest: 1-2 days; Activity restriction: 3 weeks |
| II | Subcapsular hematoma 10-50%; laceration 1-3 cm | ICU: 0-1 day; Bed rest: 2-3 days; Activity restriction: 4 weeks |
| III | Subcapsular hematoma >50% or expanding; laceration >3 cm or involving trabecular vessels | ICU: 1-2 days; Bed rest: 3-4 days; Activity restriction: 5-6 weeks |
| IV | Laceration involving segmental or hilar vessels with >25% devascularization | ICU: 2-3 days; Bed rest: 4-5 days; Activity restriction: 6-8 weeks |
| V | Shattered spleen or hilar vascular injury with devascularized spleen | Consider operative management if unstable; if stable, ICU: 3+ days; Activity restriction: 8-12 weeks |
Liver Injury Management
- Similar NOM principles apply; success rate >90%
- ICU monitoring duration and activity restriction generally parallel spleen injury guidelines by grade
- Indications for operative intervention: hemodynamic instability despite resuscitation (>40 mL/kg crystalloid + blood), peritonitis, hollow viscus injury, transfusion requirement >40 mL/kg pRBCs in 24 hours
- Angioembolization: increasingly used for active extravasation on CT (blush) in stable or transiently responding patients, as an alternative to operative management
4.4 Pediatric Trauma: Key Differences from Adults
| Feature | Pediatric Consideration |
|---|---|
| Head | Proportionally larger head → higher center of gravity → head injuries more common; thinner cranial vault → more vulnerable to fracture; larger subarachnoid space provides some protection |
| Airway | Larger tongue relative to oral cavity; more anterior and cephalad larynx; shorter trachea; narrowest at cricoid ring (not glottis); cuffed ETT preferred (correct sizing crucial) |
| C-spine | Fulcrum of flexion at C2-C3 in young children (vs C5-C6 in adults); ligamentous laxity allows SCIWORA (spinal cord injury without radiographic abnormality); pseudosubluxation of C2 on C3 is normal variant |
| Chest | Compliant rib cage → pulmonary contusion without rib fracture; rib fractures in young children suggest MASSIVE force and should raise concern for NAT |
| Abdomen | Less subcutaneous fat and muscle mass → less protection for solid organs; solid organs proportionally larger; bladder is an intra-abdominal organ in young children |
| Skeleton | More cartilaginous → Salter-Harris fractures through growth plates; plastic (bowing) deformity and greenstick fractures; healing faster than adults |
| Blood volume | 80 mL/kg (higher per kg than adults at 70 mL/kg); small absolute volumes mean small losses are proportionally significant |
| Hypothermia | Greater BSA:mass ratio → heat loss more rapid; hypothermia exacerbates coagulopathy and acidosis |
5. Non-Accidental Trauma (Child Abuse)
Child abuse is a leading cause of injury-related death in children under 5 years of age. Emergency physicians have a legal and ethical obligation to identify and report suspected abuse. Failure to recognize abuse at the sentinel event leads to recurrent abuse in 35-50% of cases, with a mortality rate of approximately 10% on re-injury.7
5.1 Sentinel Injuries
Sentinel injuries are seemingly minor injuries (bruises, intraoral injuries) that precede more severe abusive injuries. Recognition of sentinel injuries is critical for early intervention.
| Injury Type | High Suspicion for Abuse |
|---|---|
| Bruising in pre-mobile infants | ANY bruise in a child not yet cruising (<6 months) is suspicious — “those who don’t cruise rarely bruise” |
| Patterned bruises | Loop marks (cord/belt), linear marks, bite marks, hand slap marks, ligature marks |
| Location | Ears (especially posterior pinna), neck, trunk, buttocks, genitalia, face (cheeks in infants); bruises NOT over bony prominences |
| Multiple bruises in various stages of healing | Though dating bruises by color is unreliable, clustered bruises in atypical locations are concerning |
| Frenulum tear in infant | Forced bottle feeding or direct blow |
| Subconjunctival hemorrhage in infant | Without history of birth trauma or coagulopathy |
5.2 Fractures Suspicious for Abuse
| Fracture Type | Significance |
|---|---|
| Classic metaphyseal lesion (CML, “corner” or “bucket-handle” fracture) | Highly specific for abuse; caused by torsional/shearing forces to extremity |
| Posterior rib fractures | Highly specific for abuse in infants; caused by squeezing/compression |
| Multiple fractures in different stages of healing | Highly specific for repetitive injury |
| Skull fractures: complex, bilateral, crossing suture lines, depressed | More concerning than simple linear parietal fractures |
| Spiral fracture of long bone in non-ambulatory child | Concerning unless witnessed accidental mechanism |
| Femur fracture in child <1 year (non-ambulatory) | Abuse until proven otherwise |
| Scapula, sternum, or spinous process fractures | Rare in accidental injury; highly suspicious |
5.3 Screening Protocol
| Age | Workup for Suspected Abuse |
|---|---|
| <2 years | Skeletal survey (complete radiographic series: AP and lateral skull, AP chest, lateral spine, AP pelvis, AP of all 4 extremities including hands and feet); follow-up skeletal survey in 2 weeks to detect healing fractures |
| <6 months | Skeletal survey + head CT without contrast (or MRI if stable) to evaluate for intracranial hemorrhage; ophthalmologic exam for retinal hemorrhages |
| All ages | Laboratory studies: CBC with differential, CMP, lipase, UA, PT/INR, PTT, fibrinogen, von Willebrand panel (rule out bleeding diathesis); AST/ALT as screening for occult abdominal trauma (if >80 IU/L, obtain CT abdomen/pelvis) |
| All ages with concern for abusive head trauma | CT head → follow with MRI brain (more sensitive for diffuse axonal injury, parenchymal injury); dilated fundoscopic exam by ophthalmologist (retinal hemorrhages present in 75-90% of abusive head trauma) |
5.4 Mandatory Reporting
- All healthcare providers are mandated reporters in all 50 US states and most countries
- Report to child protective services (CPS) and/or law enforcement when there is reasonable suspicion of abuse — proof is NOT required
- Document findings meticulously: use body diagrams, photograph injuries with scale marker, record history from caregiver and child (separately when possible) using direct quotes
- Do not discharge the child to the suspected abuser; ensure safe disposition through CPS involvement
- If the child requires hospitalization for medical reasons, this provides a safe environment while the investigation proceeds7
6. Neonatal Emergencies
6.1 Neonatal Hypoglycemia
Neonatal hypoglycemia is one of the most common metabolic problems in newborns. Risk factors include maternal diabetes (infant of diabetic mother, IDM), small for gestational age (SGA), large for gestational age (LGA), prematurity, perinatal stress, and inborn errors of metabolism.8
| Scenario | Threshold | Management |
|---|---|---|
| Asymptomatic at-risk neonate (<4 hours old) | Blood glucose <25 mg/dL | Feed immediately (breast or formula); recheck in 1 hour; if still <25, begin D10W IV |
| Asymptomatic at-risk neonate (4-24 hours old) | Blood glucose <35 mg/dL | Feed and recheck in 1 hour; if still <35, begin D10W IV |
| Symptomatic at any age (jitteriness, lethargy, hypotonia, seizures, apnea, poor feeding, hypothermia) | Any confirmed glucose <40 mg/dL with symptoms | D10W 2 mL/kg IV bolus over 1-2 minutes → D10W continuous infusion at glucose infusion rate (GIR) of 5-8 mg/kg/min; calculate GIR = (IV rate in mL/hr × dextrose concentration × 1000) / (weight in kg × 60 × 100) |
| Persistent hypoglycemia (requiring GIR >10-12 mg/kg/min) | Refractory | Increase dextrose concentration (D12.5W or D15W via central line); consider hydrocortisone 5 mg/kg/day divided q12h; diazoxide 5-15 mg/kg/day divided q8h for hyperinsulinism; glucagon 0.03 mg/kg IM/IV; endocrinology consultation |
6.2 Congenital Heart Disease (Duct-Dependent Lesions)
Critical congenital heart disease (CHD) presents in the neonatal period, often when the ductus arteriosus begins to close (typically within the first 24-72 hours but may be delayed to 1-2 weeks of life). Prostaglandin E1 (PGE1, alprostadil) maintains ductal patency and is the critical bridge to definitive surgical intervention.9
Duct-Dependent Lesions
| Category | Lesions | Clinical Presentation |
|---|---|---|
| Duct-dependent pulmonary blood flow (right-sided obstructive) | Critical pulmonary stenosis; pulmonary atresia; tricuspid atresia; tetralogy of Fallot (severe); Ebstein anomaly (severe) | Cyanosis (SpO2 typically 60-85%); minimal respiratory distress initially; failure to improve with supplemental oxygen (hyperoxia test: PaO2 remains <100 mmHg on 100% FiO2) |
| Duct-dependent systemic blood flow (left-sided obstructive) | Hypoplastic left heart syndrome (HLHS); critical coarctation of aorta; interrupted aortic arch; critical aortic stenosis | Shock — pallor, poor pulses, acidosis, hepatomegaly; may present after duct closure with acute cardiovascular collapse; differential cyanosis (higher SpO2 in right hand than feet for coarctation/interrupted arch) |
| Duct-dependent mixing | Transposition of the great arteries (d-TGA) | Severe cyanosis unresponsive to oxygen; requires balloon atrial septostomy (Rashkind procedure) to improve mixing |
PGE1 (Alprostadil) Protocol
| Parameter | Details |
|---|---|
| Indication | Any neonate with suspected duct-dependent cardiac lesion |
| Starting dose | 0.05-0.1 mcg/kg/min continuous IV infusion |
| Maintenance dose | 0.01-0.05 mcg/kg/min (titrate to lowest effective dose once duct patency established) |
| Preparation | 500 mcg in 50 mL D5W or NS (10 mcg/mL) — adjust volume for concentration appropriate to patient weight and infusion pump |
| Monitoring | Continuous cardiorespiratory monitoring; temperature; oxygen saturation |
| Side effects | Apnea (12-20% — be prepared to intubate; occurs more commonly at higher doses); hypotension; fever; cutaneous flushing; bradycardia; seizures (rare, at high doses) |
| Key warning | Apnea risk necessitates that PGE1 infusions be initiated only in settings where immediate intubation capability is available |
Hyperoxia Test
| Step | Action |
|---|---|
| 1 | Obtain baseline ABG (right radial artery — pre-ductal) on room air |
| 2 | Administer 100% FiO2 via non-rebreather mask or oxygen hood for 10-15 minutes |
| 3 | Repeat ABG on 100% FiO2 |
| 4 | Interpret: if PaO2 rises to >150 mmHg → pulmonary disease likely; if PaO2 remains <100 mmHg → cyanotic congenital heart disease likely; if PaO2 50-150 → indeterminate (may be mixing lesion or severe pulmonary disease) |
6.3 Neonatal Hyperbilirubinemia
Neonatal jaundice affects 60% of term and 80% of preterm newborns. While usually benign (physiologic jaundice), severe unconjugated hyperbilirubinemia can cause acute bilirubin encephalopathy (kernicterus) with devastating neurologic consequences. Risk-based management using the Bhutani nomogram guides phototherapy and exchange transfusion thresholds.10
Risk Factors for Severe Hyperbilirubinemia
| Major Risk Factors | Minor Risk Factors |
|---|---|
| Pre-discharge total serum bilirubin (TSB) in high-risk zone (>95th percentile on Bhutani nomogram) | TSB in high-intermediate zone (75th-95th percentile) |
| Jaundice in first 24 hours of life | Gestational age 37-38 weeks |
| ABO or Rh incompatibility (positive DAT) | Previous sibling with jaundice |
| Gestational age <36 weeks | Cephalohematoma or significant bruising |
| G6PD deficiency | East Asian race |
| Prior sibling with phototherapy | Exclusive breastfeeding (especially if not going well) |
| Altitude >5,000 feet | Male sex |
Phototherapy and Exchange Transfusion Thresholds
Thresholds are based on gestational age, postnatal age (hours), and risk factors. The following are approximate values for term infants (≥38 weeks) — use nomograms for precise management.10
| Postnatal Age | Phototherapy Threshold (low-risk term) | Exchange Transfusion Threshold (low-risk term) |
|---|---|---|
| 24 hours | ~12 mg/dL | ~19 mg/dL |
| 48 hours | ~15 mg/dL | ~22 mg/dL |
| 72 hours | ~18 mg/dL | ~24 mg/dL |
| 96 hours | ~20 mg/dL | ~25 mg/dL |
Lower thresholds apply for:
- Premature infants (35-37+6 weeks: subtract ~2 mg/dL; <35 weeks: use gestational age-specific charts)
- Infants with neurotoxicity risk factors (isoimmune hemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, acidosis, albumin <3 g/dL)
Acute Bilirubin Encephalopathy — Warning Signs
| Phase | Signs |
|---|---|
| Early | Lethargy, hypotonia, poor feeding |
| Intermediate | Irritability, hypertonia (retrocollis/opisthotonos), high-pitched cry, fever |
| Advanced | Apnea, seizures, coma, death |
Emergency management: intensive phototherapy (irradiance ≥30 mcW/cm²/nm) with preparation for double-volume exchange transfusion (160-180 mL/kg) if TSB is at or near exchange transfusion threshold or if signs of acute bilirubin encephalopathy are present
7. Pediatric Medication Dosing Quick Reference Table
The following table provides a comprehensive quick-reference for commonly used medications in pediatric emergencies, with weight-based dosing, routes, and maximum doses.11
| Medication | Indication | Dose | Route | Max Dose | Key Notes |
|---|---|---|---|---|---|
| Acetaminophen | Fever, pain | 15 mg/kg | PO/PR | 1 g/dose; 75 mg/kg/day | q4-6h; avoid in hepatic failure |
| Ibuprofen | Fever, pain (>6 months) | 10 mg/kg | PO | 400 mg/dose | q6-8h; avoid if dehydrated (renal risk) |
| Ondansetron | Nausea/vomiting | 0.15 mg/kg | IV/PO | 4 mg | May give ODT for oral dosing; aids ORT success |
| Dexamethasone | Croup; asthma | 0.6 mg/kg | PO/IM/IV | 10-16 mg | Single dose for croup; 1-2 doses for asthma |
| Prednisone/Prednisolone | Asthma exacerbation | 1-2 mg/kg/day | PO | 60 mg/day | 3-5 day course |
| Methylprednisolone | Severe asthma, anaphylaxis | 1-2 mg/kg | IV | 125 mg | q6h for asthma |
| Albuterol (nebulized) | Asthma, bronchospasm | 0.15 mg/kg | Nebulized | 5 mg/dose | q20min × 3, then q1-4h PRN |
| Albuterol (continuous) | Severe asthma | 0.5 mg/kg/hr | Continuous neb | 15 mg/hr | ICU-level intervention |
| Ipratropium | Asthma (adjunct) | 0.25-0.5 mg | Nebulized | 0.5 mg | With albuterol × 3 doses in first hour only |
| Epinephrine (anaphylaxis) | Anaphylaxis | 0.01 mg/kg | IM (1:1,000) | 0.3 mg (<30 kg); 0.5 mg (≥30 kg) | Repeat q5-15 min PRN |
| Epinephrine (cardiac arrest) | Cardiac arrest | 0.01 mg/kg | IV/IO (1:10,000) | 1 mg | q3-5 min |
| Epinephrine (croup) | Croup | 0.5 mL/kg of 1:1,000 | Nebulized | 5 mL | Observe ≥2 hrs post-dose for rebound |
| Atropine | Symptomatic bradycardia | 0.02 mg/kg | IV/IO | 0.5 mg (child) | Min dose 0.1 mg |
| Adenosine (1st) | SVT | 0.1 mg/kg | Rapid IV push | 6 mg | Rapid push + NS flush |
| Adenosine (2nd) | SVT | 0.2 mg/kg | Rapid IV push | 12 mg | Rapid push + NS flush |
| Amiodarone | VF/pVT | 5 mg/kg | IV/IO bolus | 300 mg | May repeat × 2 (max 15 mg/kg/day) |
| Midazolam | Seizure | 0.2 mg/kg | IM/IN/buccal | 10 mg | First-line for no-IV seizure |
| Lorazepam | Seizure | 0.1 mg/kg | IV | 4 mg | Longer anticonvulsant duration |
| Diazepam | Seizure | 0.2 mg/kg IV; 0.5 mg/kg PR | IV/PR | 10 mg IV; 20 mg PR | Rectal gel for home/EMS use |
| Levetiracetam | Status epilepticus (2nd line) | 40-60 mg/kg | IV | 4,500 mg | Over 10-15 min |
| Fosphenytoin | Status epilepticus (2nd line) | 20 mg PE/kg | IV | 1,500 mg PE | Max rate 3 mg PE/kg/min |
| Phenobarbital | Status epilepticus (2nd line); neonatal seizures | 20 mg/kg | IV | 1,000 mg | Max rate 1 mg/kg/min |
| Ceftriaxone | Empiric sepsis (>28 days) | 50-100 mg/kg | IV | 2 g (sepsis); 4 g (meningitis) | q12-24h; avoid in neonates with hyperbilirubinemia (displaces bilirubin from albumin) |
| Ampicillin | Empiric neonatal sepsis | 50 mg/kg | IV | — | q8h (sepsis); q6h (meningitis doses: 100 mg/kg q6h) |
| Gentamicin | Empiric neonatal sepsis | 4-5 mg/kg | IV | — | q24h; monitor levels |
| Vancomycin | MRSA, meningitis adjunct | 15 mg/kg | IV | — | q6h; target trough 15-20 for meningitis |
| Acyclovir | Neonatal HSV | 20 mg/kg | IV | — | q8h; 14-21 day course |
| PGE1 (Alprostadil) | Duct-dependent CHD | 0.05-0.1 mcg/kg/min | IV infusion | — | Apnea risk — intubation readiness required |
| Mannitol | Cerebral edema | 0.5-1 g/kg | IV | — | Over 15-20 min; keep Osm <320 |
| 3% Hypertonic saline | Cerebral edema, symptomatic hyponatremia | 2-5 mL/kg | IV | — | Over 10-20 min |
| Calcium chloride 10% | Hypocalcemia, hyperkalemia | 20 mg/kg | IV (slow push) | 2,000 mg | Central line preferred; tissue necrosis if extravasation |
| Calcium gluconate 10% | Same (alternative) | 60 mg/kg | IV | 3,000 mg | Safer peripherally; 1/3 elemental Ca of CaCl |
| Magnesium sulfate | Torsades, refractory asthma | 25-50 mg/kg | IV over 10-20 min | 2 g | Monitor for hypotension, bradycardia |
| Sodium bicarbonate | Severe acidosis, hyperkalemia | 1 mEq/kg | IV slow push | — | 4.2% in neonates; 8.4% in children |
| D10W | Neonatal hypoglycemia | 2-4 mL/kg | IV | — | For neonates ONLY; follow with continuous D10W infusion |
| D25W | Infant/toddler hypoglycemia | 2-4 mL/kg | IV | — | For infants/toddlers |
| D50W | Older child hypoglycemia | 1-2 mL/kg | IV | 25 g | For older children/adolescents |
| Glucagon | Hypoglycemia (no IV access) | 0.5 mg (<25 kg); 1 mg (≥25 kg) | IM/SC | 1 mg | Onset 10-20 min |
| Naloxone | Opioid reversal | 0.1 mg/kg (full); 0.01 mg/kg (titrated) | IV/IO/IM/IN | 2 mg/dose | Titrate to respiratory effort |
| Insulin (regular) | DKA | 0.05-0.1 units/kg/hr | IV infusion | — | NO bolus in pediatric DKA |
| Tranexamic acid | Trauma-associated hemorrhage | 15-20 mg/kg IV load (max 1 g) | IV over 10 min | 1 g load; 2 mg/kg/hr infusion (max 1 g over 8 hrs) | Within 3 hours of injury |
Waseem M, Rosenberg HK. “Intussusception.” Pediatr Emerg Care. 2008;24(11):793-800. DOI: 10.1097/PEC.0b013e31818ea351 ↩︎
Olive AP, Endom EE. “Infantile Hypertrophic Pyloric Stenosis.” Pediatr Rev. 2019;40(7):370-372. DOI: 10.1542/pir.2017-0309 ↩︎ ↩︎
Sharp VJ, Kieran K, Arlen AM. “Testicular Torsion: Diagnosis, Evaluation, and Management.” Am Fam Physician. 2013;88(12):835-840. URL: https://www.aafp.org/pubs/afp/issues/2013/1215/p835.html ↩︎ ↩︎
Kuppermann N, Holmes JF, Dayan PS, et al. “Identification of Children at Very Low Risk of Clinically-important Brain Injuries After Head Trauma: A Prospective Cohort Study.” Lancet. 2009;374(9696):1160-1170. DOI: 10.1016/S0140-6736(09)61558-0 ↩︎ ↩︎
Holmes JF, Lillis K, Monroe D, et al. “Identifying Children at Very Low Risk of Clinically Important Blunt Abdominal Injuries.” Ann Emerg Med. 2013;62(2):107-116.e2. DOI: 10.1016/j.annemergmed.2012.11.009 ↩︎ ↩︎
Stylianos S, and the APSA Trauma Committee. “Evidence-Based Guidelines for Resource Utilization in Children with Isolated Spleen or Liver Injury.” J Pediatr Surg. 2000;35(2):164-169. DOI: 10.1016/S0022-3468(00)90003-4 ↩︎
Christian CW, Committee on Child Abuse and Neglect. “The Evaluation of Suspected Child Physical Abuse.” Pediatrics. 2015;135(5):e1337-e1354. DOI: 10.1542/peds.2015-0356 ↩︎ ↩︎
Adamkin DH, Committee on Fetus and Newborn. “Postnatal Glucose Homeostasis in Late-Preterm and Term Infants.” Pediatrics. 2011;127(3):575-579. DOI: 10.1542/peds.2010-3851 ↩︎
Stanger P, Lucas RV Jr, Edwards JE. “Anatomic Factors Causing Respiratory Distress in Acyanotic Congenital Cardiac Disease.” Pediatrics. 1969;43(5):760-769. DOI: 10.1542/peds.43.5.760 ↩︎
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. “Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.” Pediatrics. 2004;114(1):297-316. DOI: 10.1542/peds.114.1.297 ↩︎ ↩︎
Lexicomp. Pediatric and Neonatal Dosage Handbook, 29th ed. Hudson, OH: Wolters Kluwer; 2023. URL: https://www.wolterskluwer.com/en/solutions/lexicomp ↩︎